The 185delAG BRCA1 mutation originated before the dispersion of Jews in the Diaspora and is not limited to Ashkenazim

Human Molecular Genetics

Volumn 7, Issue 5, 1998, Pages 801-805

  Bruchim Bar Sade, Revital ^a   Kruglikova, Anna ^a   Modan, Baruch ^a   Gak, Eva ^b   Hirsh Yechezkel, Galit ^a   Theodor, Livia ^a   Novikov, Ilya ^a   Gershoni Baruch, Ruth ^c   Risel, Shulamit ^a   Papa, Moshe Z ^a   Ben Baruch, Gilad ^a   Friedman, Eitan ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; DNA SEQUENCE; FAMILY HISTORY; GENE LOCUS; GENE MUTATION; HUMAN; JEW; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC SCREENING; GERM-LINE MUTATION; HETEROZYGOTE DETECTION; HUMANS; IRAN; JEWS; MIDDLE AGED; MOROCCO; OVARIAN NEOPLASMS; SEQUENCE DELETION; TURKEY; YEMEN;

INVERTEBRATA; IRANIA;

EID: 7144251883     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.5.801     Document Type: Article

References (21)

1. IARC (1987) Cancer Incidence in Five Continents, Vol. 5. IARC, Lyon.
2. Israel Cancer Registry (1995) Cancer in Israel 1993: Facts and Figures. Ministry of Health, Jerusalem.
3. Roa, B.B., Boyd, A.A., Volick, K. and Richards, C.S. (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet., 14, 185-187.
4. Odduoux, C., Streuwing, J.P., Clayton, C.M., Neuhausen, S., Brody, L.C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., Goldgar, D., Ostrer, H. and Offit, K. (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genet., 14, 188-190.
5. Streuwing, J.P., Abeliovitch, D., Peretz, T., Avishai, N., Kaback, M.M., Collins, F.S. and Brody, L.C. (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet., 11, 198-200.
6. Langston, A.A., Malone, K.E., Thompson, J.D. and Ostrander, E.A. (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med., 334, 137-142.
7. FitzGerald, M.G., MacDonald, D.J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arielo, H., Finkelstein, D.M., Beer-Romero, P., Englert, C., Sgori, D.C., Smith, B.L., Younger, I.W., Garber, J.E., Duda, A.B., Mayzel, K.A., Isselbacher, K.J., Friend, S.H. and Haber, D.H. (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early onset breast cancer. N. Engl. J. Med., 334, 143-149.
8. Berman, D.B., Wagner-Costalas, J., Schultz, D.C., Lynch, D.C., Daly, M. and Goodwin, A.K. (1996) Two distinct origins of a common mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am. J. Hum. Genet., 58, 1166-1176.
9. Neuhausen, S.L., Mazoyer, S., Friedman, L., Stratton, M., Offit, K., Caligo, A.,Tomlinson, G., Cannon-Albright, L., Bishop, T., Kelsell, D., Solomon, E., Weber, B., Couch, F., Streuwitig, J., Tonin, P., Durcher, F., Narod, S., Skolnick, M.H., Lenoir, G., Serova, O., Ponder, B., Stoppa-Lynnrd, D., Easton, D., King, M.C. and Goldgar, D. (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am. J. Hum. Genet., 58, 271-280.
10. Sher, C., Sharabani-Gargir, L. and Shohat, M. (1996) Breast cancer and BRCA1. N. Engl. J. Med., 334, 1199.
11. Abeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., Zlotogora, J., Heching, N. and Peretz, T. (1997) The founder mutation 185delAG and 5382InsC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet., 60, 505-514.
12. Bruchim Bar-Sade, R., Theodor, L., Gak, E., Kruglikova, A., Hirsh-Yechezkel, G., Modan, B., Kuperstein, G., Seligsohn, U., Rechavi, G. and Friedman, E. (1997) Could the 185delAG BRCA1 mutation be an ancient Jewish mutation? Eur. J. Hum. Genet., 51, 413-416.
13. Shpilberg, O., Peretz, H., Zivelin, A., Yatuv, R., Chetrit, A., Kulka, T., Stern, C., Weiss, E. and Seligsohn, U. (1995) One of the two common mutations causing factor X1 deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood, 85, 429-432.
14. William, A. and Rubinstein, D.C. (1996) Microsatellites are subject to directional evolution. Nature Genet., 12, 13-14.
15. William, A. and Rubinstein, D.S. (1996) Microsatellites show mutational bias and heterozygote instability. Nature Genet., 13, 390-391.
16. Goodman, R.M. (1979) A perspective of genetic diseases among the Jewish people. In Goodman, R.M and Moutulsky, A.G. (eds), Genetic Diseases among Ashkena:i Jews. Raven Press, New York.
17. Bonne-Tamir, B., Zoosman-Disakin, A. and Ticher, A. (1992) Genetic diversity among Jews re-examined: preliminary analysis at the DNA level. In Bonne-Tamir, B. and Adam, A. (eds), Genetic Diversity among Jews. Diseases and Markers at the DNA Level. Oxford University Press, Oxford, pp. 80-94.
18. Szabo, C.I. and King, M.C. (1997) Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet., 60, 1013-1020.
19. Friedman, L.S., Ostermeyer, E.A., Szabo, C.I., Dowd, P., Lynch, E.D., Powell, S.E. and King, M.C. (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet., 8, 399-404.
20. Ozelik, H., Antebi, Y.J., Cole, D.E.C. and Andrulis, I.L. (1996) Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation. Hum Genet., 98, 310-312.
21. Syvänen, A.C., Aalto-Setälä, K., Kontula, K. and Söderlund, H. (1989) Direct sequencing of affinity captured amplified human DNA: application to the detection of apolipoprotein E polymorphism. FEBS Lett., 258, 71-74.